VistaGen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · IEX Real-Time Price · USD
3.330
-0.240 (-6.72%)
At close: Jul 2, 2024, 4:00 PM
3.320
-0.010 (-0.30%)
After-hours: Jul 2, 2024, 6:11 PM EDT
VistaGen Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for VTGN stock have an average target of 19, with a low estimate of 12 and a high estimate of 30. The average target predicts an increase of 470.57% from the current stock price of 3.33.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 7, 2023.
Analyst Ratings
The average analyst rating for VTGN stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $0.2 → $15 | Hold → Strong Buy | Upgrades | $0.2 → $15 | +350.45% | Dec 7, 2023 |
| Stifel | Stifel | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +260.36% | Nov 14, 2023 |
| Maxim Group | Maxim Group | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | +800.90% | Sep 5, 2023 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $30 | Hold → Strong Buy | Upgrades | $30 | +800.90% | Aug 7, 2023 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 26, 2022 |
Financial Forecast
Revenue This Year
303.45K
from 1.06M
Decreased by -71.48%
Revenue Next Year
268.60K
from 303.45K
Decreased by -11.49%
EPS This Year
-2.06
from -1.52
EPS Next Year
-1.92
from -2.06
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 829,500 | 829,500 | 5.3M | 73.3M | 273.4M |
| Avg | 303,450 | 268,597 | 2.6M | 71.2M | 265.6M |
| Low | n/a | n/a | n/a | 68.5M | 255.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -22.0% | 173.4% | 1,854.6% | 2,776.2% | 283.7% |
| Avg | -71.5% | -11.5% | 849.4% | 2,694.0% | 272.8% |
| Low | - | - | - | 2,584.5% | 258.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.91 | -1.33 | -1.61 | -0.98 | 1.29 |
| Avg | -2.06 | -1.92 | -1.88 | -0.95 | 1.25 |
| Low | -2.19 | -2.88 | -2.12 | -0.91 | 1.21 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.